Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany-Reference-Cited by-同舟云学术

Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany

Published:2005-10 Issue:7 Volume:14 Page:476-484
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Opp Joachim,Tuxhorn Ingrid,May Theodor,Kluger Gerhard,Wiemer-Kruel Adelheid,Kurlemann Gerd,Gross-Selbeck Gunther,Rating Dietz,Brandl Ulrich,Bettendorf Ulrich,Härtel Christoph,Korn-Merker Elisabeth

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference24 articles.

1. Efficacy and tolerability of Levetiracetam 3000mg/day in patients with refractory partial seizures: a multicenter double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group;Ben-Menachem;Epilepsia,2000

2. Levetiracetam for partial seizures: results of a double blind, randomized clinical trial;Cereghino;Neurology,2000

3. Multicenter double-blind, randomized, placebo-controlled trial of Levetiracetam as add-on therapy in patients with refractory partial seizures;Shorvon;Epilepsia,2000

4. Pharmacokinetic study of Levetiracetam in children;Pellock;Epilepsia,2002

5. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam;Mula;Seizure,2004

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Hypoxic-Ischemic Encephalopathy Using Measures Other Than Therapeutic Hypothermia;Principles of Neonatology;2024

2. The efficacy and safety of first-line anti-seizure medications as substitution therapy for children with drug-resistant epilepsy: a randomized controlled trial protocol;Frontiers in Neurology;2023-08-07

3. Modified Atkins diet versus levetiracetam for non-surgical drug-resistant epilepsy in children: A randomized open-label study;Seizure;2022-12

4. Antikonvulsiva;Kinder- und Jugendmedizin;2022-11

5. Evaluation of the efficacy and tolerability of levetiracetam as add-on therapy in intractable epilepsy of children;IRAN J CHILD NEUROL;2022